Since tumor expression of CD200 differentially affect tumor formation in the subcutaneous model versus the lung metastatic model, we hypothesized that the lung and peripheral tumor microenvironment decided the differential susceptibility to CD200-mediated suppression of tumor growth. This evidence concerns the gene CD200 and neoplasm.